Committee Listing

Grant Garrigues, MD
Andrew Green, MD
Carolyn Hettrich, MD

Melissa Wright, MD

Michael L. Pearl, MD

Julie Y. Bishop, MD

Surena Namdari, MD, MSc

Leesa M. Galatz, MD

Mark A. Mighell, MD
Surena Namdari, MD, MSc
Gregory P. Nicholson, MD

Brian Badman, MD

John G. Costouros, MD, FACS

Leesa M. Galatz, MD
John E. (Jed) Kuhn, MD, MS
Christopher C. Schmidt, MD

Sara Edwards, MD
Michael Cusick, MD

April D. Armstrong, MD, FRCSC
Jonathan P. Braman, MD
John G. Costouros, MD, FACS
Charles L. Getz, MD
Jonathan C. Levy, MD
Thomas (Quin) W. Throckmorton, MD

Julie Y. Bishop, MD
Theodore A. Blaine, MD
Xavier A. Duralde, MD
John C. Macy, MD
Eric T. Ricchetti, MD
Brian R. Wolf, MD, MS

Grant E. Garrigues, MD

Asheesh Bedi, MD
Brad Bushnell, MD
Alison Cabrera, MD
Matthew Saltzman, MD
Charles Jobin, MD

Michael Amini, MD, Co-Chair
Justin W. Griffin, MD, Co-Chair
Andrew Sheean, MD, Co-Chair
Albert Lin, MD, Ex-Officio
Eric R. Wagner, MD, MS, Ex-Officio

Joaquin Sanchez-Sotelo, MD, PhD
Scott P. Steinmann, MD

Scott P. Steinmann, MD

Heinze R. Hoenecke, MD, Co-chair
Nikhil N. Verma, MD, Co-chair
Andrew Green, MD
Michael Pearl, MD
Anthony Romeo, MD
John W. Sperling, MD
Robert Tashjian, MD
Matthew Teusink, MD
George Athwal, MD
Kevin Plancher
Theodore Schlegel, MD
Thomas Throckmorton, MD
Michael S. Khazzam, MD
Edwin E. Spencer, MD
Carolyn M. Hettrich, MD
April D. Armstrong, MD, FRCSC
Peter B. MacDonald, MD, FRCSC
Bradford O. Parsons, MD
Xavier A. Duralde, MD
Joaquin Sanchez-Sotelo, MD, PhD
Frances Cuomo, MD
Sara L. Edwards, MD
Oke A. Anakwenze, MD
W. Benjamin Kibler, MD
Peter B. MacDonald, MD, FRCSC, Board Liaison
John E. (Jed) Kuhn, MD, Board Liaison

Joaquin Sanchez-Sotelo, MD, PhD

Howard Routman, MD, Chair
Abdulaziz F. Ahmed, MD
Michael Amini, MD
Andrew T. Assenmacher, MD
Michael Bahk, MD
Matthew Baker, MD
Daniel Brereton, MD
Danielle Casagrande, MD
Aakash Chauhan, MD
Adnan N. Cheema, MD
Raymond E. Chen, MD
Joseph Choi, MD
Daniel Davis, MD
Matthew Dilisio, MD
Robert James Gillespie, MD
James Gregory, MD
Konrad Gruson, MD
John Haverstock, MD
Ryan Hoffman, MD
Andrew Jawa, MD
Andrew Jensen, MD
Utku Kandemir, MD
Hafiz Kassam, MD
Joey LaMartina II, MD
Joseph Liu, MD
Adam Lorenzetti, MD
Kevin Michael Magone, MD
Surena Namdari, MD
Wesley Nottage, MD
Jeffrey J Olson, MD
Nathan D. Orvets, MD
Brendan M. Patterson, MD, MPH
Scott Paxton, MD
Austin F Smith, MD
Jeffrey Sodl, MD
Jeremy Somerson, MD
Daniel J. Song, MD
Laura Stoll, MD
Michael Stone, MD
John Swab, DO
Matthew Teusink, MD
Timothy Uhl, PhD
Alexander Vap, MD
Michael Walsh, MD
Brent Wiesel, MD
Edward Yian, MD

John. E. (Jed) Kuhn, MD, Chair

Sara L. Edwards, MD, Chair
Oke A. Anakwenze, MD, Co-Chair
Ivan A. Garcia, MD
Carolyn M. Hettrich, MD, MPH
Gabriella Ode, MD
Brent Stephens, MD
Katherine B. Vadasdi, MD
Joaquin Sanchez-Sotelo, MD, PhD, Board Liaison

Rachel M. Frank, MD, Chair
Jason L. Koh, MD, Co-Chair
Daniel C. Acevedo, MD
Stephen Brockmeier, MD
Shannon R. Carpenter, MD
Peter N. Chalmers, MD
Evan S. Lederman, MD
Melissa Wright, MD
Wesley P. Phipatanakul, MD
Robert Gillespie, MD, Ex-Officio
Ronald A. Navarro, MD, Ex-Officio

Ranjan Gupta, MD, Co-Chair
Samer S. Hasan, MD, PhD, Co-Chair
Randall J. Otto, MD, Secretary
Jessica G. Aronowitz, MD
George S. Athwal, MD, FRCSC
Theodore A. Blaine, MD
Michael Boin, MD
R. Alexander Creighton, MD
Kevin Cronin, MD
Daniel E. Davis, MD
Brandon J. Erickson, MD
James M. Gregory, MD
R. Michael Greiwe, MD
G. Dean Harter, MD
Jason C. Ho, MD
Tyler Johnston, MD
Shahbaz Malik, MD
Walter B. McClelland Jr, MD
Surena Namdari, MD, MSc
James V. Nepola, MD
Andrew S. Neviaser, MD
Elizabeth M. Nolan, MD
Kaveh Sajadi, MD
Matthew Saltzman, MD
Paul M. Sethi, MD
Kevin P. Shea, MD
Lewis L. Shi, MD
Matthew Smith, MD
Laura Stoll, MD
Jennifer Tangtiphaiboontana, MD
Ilya Voloshin, MD
Ivan Wong, MD
Xavier A. Duralde, MD, Board Liaison
George S. Athwal, MD, FRCSC, Board Liaison

Luke S. Austin, MD, Chair
Mena M. Mesiha, MD, Secretary
John D. Kelly IV, MD
Joaquin Sanchez-Sotelo, MD, PhD, Board Liaison

Umasuthan (Uma) Srikumaran, MBA, MD, MPH, Chair
Jay Keener, MD
Joseph Choi, MD
Christopher R. Chuinard, MD, MPH
Phani K. Dantuluri, MD
Roberto Ikemoto, MD
Joseph J. King III, MD
Andrew Jensen, MD
Thay Lee, PhD
Mark Mighell, MD
Eloy Tabeayo Alvarez, MD
Thomas (Quin) W. Throckmorton, MD
Edward Yian, MD
Peter MacDonald, MD, FRCSC, Ex-Officio
Mark A. Frankle, MD, Board Liaison

Thomas W. Wright, MD, Chair
Shannon R. Carpenter, MD, Co-Chair
Aaron M. Chamberlain, MD
Raymond Edward Chen, MD
David N. Collins, MD
Michael T. Freehill, MD
Brian F. Grogan, MD
Brian K. Lee, MD
Daryl C. Osbahr, MD
Dane H. Salazar, MD
Adam Seidl, MD
J. Michael Wiater, MD
Xavier A. Duralde, MD, Board Liaison
George S. Athwal, MD, FRCSC, Board Liaison

Charles L. Getz, MD, Chair 
Jennifer Lane Vanderbeck, MD, Secretary
Richard Friedman, MD
Abner Ward, MD
Nikhil N. Verma, MD
Peter MacDonald, MD, Ex-Officio
Charles L. Getz, MD, Board Liaison
Julie Bishop, MD, Board Liaison

Jeffrey S. Abrams, MD, Co-Chair
Bradford O. Parsons, MD, Co-Chair
Yousif Atwan, MD
Josh Baumfeld, MD
Tyler Brolin
Derek J. Cuff, MD
Joshua S. Dines, MD
Hafiz F. Kassam, MD, FRCSC
John D. Kelly, IV, MD
Steven D. Levin, MD
Robert B. Litchfield, MD, FRCSC
Drew V. Miller, MD
Raffy Mirzayan, MD
Dave Shukla, MD
Anthony A. Romeo, MD
Brian Shiu, MD
Abner M. Ward, MD, MBA, MA, FACS

H. Mike Kim, MD

Robert Litchfield, MD

Emilie V. Cheung, MD, Co-Chair
Jason O. Holcomb, MD, Co-Chair
Joseph N. Liu, MD, Secretary
Ryan T. Bicknell, MD
Kamal Bohsali, MD
Eddy Echols Jr, MD
Andrew Jawa, MD
Kelly G. Kilcoyne, MD
Marc S. Kowalsky, MD
Wesley P. Phipatanakul, MD
Eric T. Ricchetti, MD
Arif Saleem, MD
Michael Stone, MD
Todd Twiss, MD
Brian R. Waterman, MD
Peter MacDonald, MD, FRCSC, Ex-Officio
John E. (Jed) Kuhn, MD, Board Liaison

Ronald A. Navarro, MD, Chair
Robert J. Gillespie, MD, Co-Chair
Peter S. Vezeridis, MD, Secretary
Shariff K. Bishai, MS, DO
Kamal I. Bohsali, MD
Katherine A. Burns, MD
Mark T. Dillon, MD
Matthew J. Dubiel, MD
Mohit N. Gilotra, MD
Konrad I. Gruson, MD
Charles M. Jobin, MD
Christopher Joyce, MD
Jason R. Kang, MD
Jack E. Kazanjian, DO
James D. Kelly II, MD
Eitan Kohan, MD
Marc S. Kowalsky, MD
Jonathan Levy, MD
Victoria Ann Lilling, MD
Albert Lin, MD
Randall Otto, MD
E. Scott Paxton, MD
Scott Pennington, MD
Matthew Saltzman, MD
Anshuman Singh, MD
David M. Weinstein, MD
John E. (Jed) Kuhn, MD, Board Liaison

John E. (Jed) Kuhn, MD, MS, Chair
Carolyn Hettrich, MD, Co-Chair
Joseph A. Abboud, MD
Michael H. Amini, MD
Jonathan D. Barlow, MD, MS
Akin Cil, MD
Josef K. Eichinger, MD
Mark A. Frankle, MD
Lawrence V. Gulotta, MD
Gabriel (Gabe) Horneff III, MD
Jason E. Hsu, MD
Joseph J. King III, MD
David Kovacevic, MD
Bryan J. Loeffler, MD
Mark E. Morrey, MD
Andrew S. Neviaser, MD
Michael J. O’Brien, MD
Luke S. Oh, MD
Jonathan C. Riboh, MD
Eric T. Ricchetti, MD
Christopher C. Schmidt, MD
Bradley S. Schoch, MD
Peter Simon, PhD

Acromioclavicular Injury Group.  Geoffrey Abrams MD
Controversy exists on the appropriate way to classify and treat acromioclavicular joint injuries.  The Acromioclavicular Injury group is addressing these controversies by finding consensus using the Delphi method, looking at failure mechanisms after surgery and developing outcomes measures and collection strategies to set up outcomes database.

B2 Glenoid Group.  Eric Ricchetti
Management of posterior glenoid bone loss (Walch B2 and B3 glenoids) in patients indicated for shoulder arthroplasty due to end-stage glenohumeral osteoarthritis can be challenging to address at the time of surgery and has been shown to impact clinical outcomes and implant longevity. The distinguishing features of these pathologies, and the factors associated with clinical and radiographic outcomes with different shoulder arthroplasty options in these patients are still not well understood.  Therefore, the mission of the ASES B2 Glenoid Multicenter Research Group is to better understand the defining features of the Walch B2 and B3 glenoid, and to investigate key cohorts of patients with these glenoid morphologies undergoing shoulder arthroplasty to determine the factors related to postoperative clinical and radiographic outcomes at short- and longer-term follow-up. 

Complications of Reverse Arthroplasty Group.  Larry Gulotta
Our mission is to decrease the rate of complications following reverse shoulder arthroplasty through a multicenter initiative.  The first task is to identify the types and rates of various complications using modern implants.  A systematic review of all papers on reverse shoulder arthroplasty published after 2010 has recently been submitted for publication as a two-part series.  In this study, we determined that most major complications have decreased over the years as implants and techniques have improved.  However, acromial and scapular spine stress fractures continue to be a devastating complication that adversely effects the long-term outcome, and for which there are currently limited treatment options.  Therefore, the second task is to specifically study acromial and scapular spine stress fractures.  Under the direction of Andy Jawa, the members of the task force have compiled our retrospective data on this complication to determine patient and implant-related risk factors.  This data has been accepted for presentation at this year’s ASES meeting.  The third task will be to use the information learned from the literature review and retrospective studies in order to devise prospective and interventional studies that can further limit complication after reverse shoulder arthroplasty.

Natural History of Shoulder Arthritis.  Andy Green
Glenohumeral osteoarthritis is a well-recognized condition that causes shoulder pain and dysfunction.  Most of the reported literature on glenohumeral osteoarthritis is focused on the surgical management of advanced stages of the condition.  However, patients present with glenohumeral OA in various stages of pathology and with variable severity of clinical manifestations. Although it is assumed that glenohumeral OA is a progressive disease and condition, there is a paucity of information available regarding the progression of pathology and clinical manifestations. The goal of the Natural History of Glenohumeral Osteoarthritis (NHGOA) multicenter study group is to evaluate the clinical and pathologic manifestations of this condition to provide an understanding of the relationship between the pathoanatomy and clinical manifestations of glenohumeral osteoarthritis and the progression of the condition over time. 

Periprosthetic Joint Infection Group.  Jason Hsu
The ASES Shoulder Periprosthetic Joint Infection (PJI) / Revision Arthroplasty Research group is focused on improving the prevention, diagnosis, and management of infections that occur after shoulder replacement. There currently is little consensus on optimal treatment for potential shoulder PJI. We have established a multicenter REDCap database, and members of this group have been enrolling all consecutive revision arthroplasty patients. A standardized workup for infection has been established. Data from this group will help us optimize diagnosis and treatment of potential infection encountered at revision arthroplasty and will help guide the next iteration of the International Consensus Meeting (ICM) definition for shoulder PJI.

SLAP/Biceps Study Group.  Tiger Li
The SLAP/Biceps Study Group is working to outline and understand the history of the superior labral pathology and the biceps tendon and its anchor and attachment.  Our intent is to define a new description of the terms utilized to describe and classify superior labral and biceps anchor pathology to better direct diagnosis and treatment through the development of a multi-center, prospective, observational study of athletes and active individuals with injuries to the superior labrum and biceps anchor managed with operative and non-operative treatment.  A particular focus will include throwing athletes with the intent to determine the optimal method of diagnosis, classification and treatment through a comprehensive analysis using imaging, functional outcomes and a robust registry capturing specific data focused on return to play. 

MERIT, Massive Cuff Tear Group.  David Kovacevic, Christopher Schmidt
We are a multinational research collaborative whose primary purpose is to better understand, to evaluate, and to investigate the natural history of massive rotator cuff injury and repair.  We will achieve this through an interdisciplinary approach, emphasizing continued development of a prospective observational cohort, establishing, and performing prospective, randomized clinical trials, and improving the tools for measuring clinical outcomes.  Our interdisciplinary team consists of surgeons, scientists, physical therapists, and most importantly, our patients. Collectively, our stakeholder group aims to be the pre-eminent global think tank for improving the lives of patients with massive rotator cuff injury.

Partial Thickness Rotator Cuff Tear Group.  Mike Kim, Jim Leonard
Partial-thickness rotator cuff tears are one of the most common conditions that are seen and treated in the shoulder and elbow surgery field. Our group is seeking to answer some of the challenging yet fundamental questions about this very common conditions. We are specifically looking at the diagnostic performance of imaging modalities, effectiveness of nonoperative treatment, risk factors for failure of nonoperative treatment, and ultimately optimal treatment decision making for individual patients with a partial-thickness rotator cuff tear.

Shoulder Arthritis in the Young Patient Group.  Joseph Abboud
The treatment of glenohumeral osteoarthritis in the young patient remains a challenge for both treating surgeons and patients. Younger patients tend to live more active lifestyles and have longer projected life expectancies, and that can lead to concerns regarding prosthetic longevity and the future need for revision surgery. As such, surgical options for these patients revolve between arthroscopic management and shoulder replacement. The purpose of this study is to determine the survival rate and outcomes of young osteoarthritis patients managed by arthroscopic surgery or by shoulder arthroplasty. The aim is to conduct a multicenter study to follow the patients’ outcomes, extrapolate best treatment strategies, predict complication rates, and derive patient-specific variables that affect prognosis.

Instability with Bone Loss Group.  Brian Lau

The ASES Shoulder Instability Bone Loss committee is studying innovative ways to measure and address glenoid and humeral bone loss. We have evaluated the use of 3D MRI and clinical decision making and hope to develop improved techniques of pre-operative assessment of bone loss. We also hope to develop evidence-based indications for utilization of innovative bone block procedures for glenoid bone loss and treatment algorithms for humeral bone loss.

Proximal Humerus Fracture Group.  Jay King
The overarching goal of the ASES Proximal Humerus Fracture multicenter group is to help improve the algorithm that surgeons can use to treat proximal humerus fractures.  Proximal humerus fractures are one of the most common fractures seen in elderly patients.  While fixation is optimal in young patients, a gold standard treatment algorithm to optimize outcomes in elderly patients does not exist.  The burden of proximal humerus fractures on the aging population is great and improvements in understanding the optimal treatment for these patients is necessary.  The ASES Proximal Humerus Fracture multicenter group is attempting to construct this algorithm starting with identifying the best outcome scores to use, tracking a large cohort of patients treated for proximal humerus fractures to allow for multivariate analysis of the factors associated with good outcomes, and to test this algorithm prospectively.  We also want to add to the current literature on nonoperative treatment of these injuries.  Our hope is that we can preoperatively identify patients who would benefit from certain treatments including nonoperative treatment, internal fixation, and shoulder arthroplasty and also minimize complications associated with these treatments.

Elbow Arthroplasty Group.  Eric Wagner and Michael Gottsalk
In the multicenter TEA group, we have a couple different focuses, including retrospective and national database studies, as well as a prospective randomized controlled trial.  The retrospective and database studies are examining the outcomes of various implants, HO occurrence, and incidence/occurrence of home vs formal physical therapy.  The prospective study is randomizing patients undergoing primary TEA to in situ vs transposition of the ulnar nerve.  We hope these ultimately will serve as a foundation for future intervention related studies to examine common complications after TEA.

Elbow Arthritis in the Young Patient Group.  Gabe Horneff
Elbow arthritis is a difficult problem to address given the inherent limitations and rates of complications and failures seen in total elbow arthroplasty when compared to other forms of joint arthroplasty. For this reason, elbow arthroscopy is often utilized in the younger and more active patient population to give relief of pain, improve range of motion, and attempt to prolong the native anatomy for patients. The goal of this group is to understand the mid- and long-term outcomes of surgical treatment for elbow arthritis. We are currently prospectively examining the results of arthroscopic osteocapsular arthroplasty in young patients under the age of 60 to assess how effective the procedure is in providing relief.  

Elbow Fracture/Dislocation Group.  Akin Cil
The Elbow Fracture/Dislocation group has 15 surgeons from 15 sites all over the USA.  We are studying the best way to manage elbow fractures and dislocations, specifically radial head fractures and coronoid fractures.  We are working on finding agreement for treating elbow injuries and will be enrolling patients in a randomized trial to look at radial head prostheses (smooth versus porous coated) for severe radial head fractures, and also improve understanding and management of coronoid fracture management.

IMOCD Elbow OCD Group.  Mohit Gilotra
Elbow Osteochondritis Dissecans is a common injury in adolescent athletes with a wide range of potential imaging for diagnosis and both nonoperative and operative treatments.  Differences in care vary by patient age, size and location of lesion, sport, and region/continent.  Our goal is to determine the best modalities for diagnosing lesions that are unstable and that may require surgery.  We also want to optimize patient and lesion specific treatment for faster return to play and prevention of long-term arthritis.  Long term we are creating a prospective international registry to answer these challenging questions.  

Elbow Stiffness Group.  Bryan Loeffler
The mission of the elbow stiffness group is to conduct well designed, multicenter studies that will answer the clinical questions of how to best prevent and treat post-traumatic elbow stiffness. Planned studies include comparing operative techniques, postoperative rehab strategies, psychological barriers to improving elbow range of motion, and pharmacologic interventions to improve patient care

Elbow UCL Group.  Luke Oh
The mission of the Elbow UCL Study Group is to study optimal methods of diagnosing and treating ulnar collateral ligament injuries. The studies that we are planning include a 1) Delphi Study, 2) a surgical decision-making study in the management of the ulnar nerve at the time of UCL surgery (either repair or reconstruction), and 3) use of AI deep learning to assist in the diagnosis of UCL partial tears

Mark A. Frankle, MD, Chair
Jeffrey Abrams, MD
Joseph Iannotti, MD
Kevin Plancher, MD
Eric Ricchetti, MD

Brandon “Brad” D. Bushnell, MBA, MD, Chair
Scott Steinmann, MD, Co-Chair
Claudius Jarrett, MD, Secretary
Mina Abdelshahed, MD
Alison Lindsay Cabrera, MD
Akin Cil, MD
Patrick J. Denard, MD
Kevin Farmer, MD
Brian Hill, MD
John Timothy Moor, MD
Mark C. Pinto, MD, MBA
Joshua Port, MD
Alan Reynolds, MD
Vani J. Sabesan, MD
David Weinstein, MD
Melissa A. Wright, MD
Mark A. Frankle, MD, Board Liaison
Joaquin Sanchez-Sotelo, MD, Board Liaison

John Sperling, MD, Chair
Michael Cusick, MD
Ranjan Gupta, MD
Nady Hamid, MD
Samer Hasan, MD
Jason Koh, MD
Surena Namdari, MD
Paul Sethi, MD
Anup Shah, MD
Jennifer Tangtiphaiboontana, MD
Thomas Throckmorton, MD
Corinne VanBeek, MD
Nikhil Verma, MD
Xavier Duralde, MD, Board Liaison

Matthew Provencher, MD, 2022 Annual Meeting Co-Chair
Joaquin Sanchez-Sotelo, MD, PhD, 2022 Annual Meeting Co-Chair
Randall J. Otto, MD, 2022 Specialty Day Meeting Co-Chair
Matthew J. Teusink, MD, 2022 Specialty Day Meeting Co-Chair
Jay Keener, MD, Ex-Officio, 2023 Specialty Day Meeting Co-Chair
Katherine Vadasdi, MD, Ex-Officio, 2023 Specialty Day Meeting Co-Chair
Jonathan C. Levy, MD, Ex-Officio, 2021 Annual Meeting Co-Chair
Mark A. Mighell, MD, Ex-Officio, 2021 Annual Meeting Co-Chair
Derek J. Cuff, MD, Ex-Officio, 2021 Annual Meeting Co-Chair
Mark A. Frankle, MD, Ex-Officio
Xavier Duralde, MD, Ex-Officio 

Robert Z. Tashjian, MD, Chair
Peter Simon, PhD, Co-Chair
William Reuben Aibinder, MD
Michael H. Amini, MD
William Ciccone II, MD
Vahid Entezari, MD MMSc
Brian T. Feeley, MD
Thomas J. Gill IV, MD
Carolyn M. Hettrich, MD, MPH
John Gabriel Horneff, MD
Michael S. Khazzam, MD
H. Mike Kim, MD
Andrew F. Kuntz, MD
Peter Lapner, MD
Xinning Li, MD
Mario Henrique Lobao, MD
C. Benjamin Ma, MD
Frank A. Petrigliano, MD
Ryan Rauck, MD
Mark W. Rodosky, MD
Bradley S. Schoch, MD
Karen M. Sutton, MD
Tim L. Uhl, PhD, PT, ATC
C. Thomas Vangsness Jr, MD
Eric R. Wagner, MD, MS
Brian Werner, MD
Ivan Wong, MD
Jarret Murray Woodmass, MD
Benjamin M. Zmistowski, MD
John E. (Jed) Kuhn, MD, Board Liaison
Joaquin Sanchez-Sotelo, MD, PhD, Board Liaison

Michael J. O’Brien, MD, Co-Chair
Eric T. Ricchetti, MD – Co-Chair
Charles L. Getz, MD, Ex-Officio
Paul M. Sethi, MD, Ex-Officio

Vani J. Sabesan, MD (2020)

Grant Garrigues, MD, Chair
Ranjan Gupta, MD
Samer Hasan, MD
Christopher Klifto, MD
Michael Knudsen, MD
Augustus Mazzocca, MD
Julianna Munoz, MD
Scott Steinmann, MD
Thomas Wright, MD
John E. (Jed) Kuhn, MD, Board Liaison
George S. Athwal, MD, FRCSC, Board Liaison